ceronapril has been researched along with Hypertension in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (10.00) | 18.7374 |
1990's | 9 (90.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Higaki, J; Katsuya, T; Mikami, H; Morishita, R; Nakamura, F; Ogihara, T; Rakugi, H; Tomita, N; Yu, H | 1 |
Fujishima, M; Ibayashi, S; Nagao, T; Sadoshima, S | 1 |
Paulson, OB; Torup, M; Waldemar, G | 1 |
Doi, Y; Kagimoto, M; Kato, K; Kawasaki, K; Koga, S; Sakai, K; Sakaue, A; Sasaki, J; Takada, K; Takii, M | 1 |
Brass, EP; Brennan, JJ; Cutler, NR; Kurtz, NM; Luna, A; Mena, I; Sramek, JJ | 1 |
Chikugo, TA; Hamada, Y; Niisato, E; Ohta, Y; Okamoto, K; Otori, T; Suzuki, T | 1 |
Kaneko, K; Osugi, S; Shimamura, K; Sunano, S; Yamamoto, K | 1 |
Katsumura, H; Ogawa, N; Ohara, N; Ono, H; Takizawa, M; Yokota, S | 1 |
DeForrest, JM; Hammerstone, S; Harvey, C; Karanewsky, D; Powell, JR; Scalese, R; Waldron, TL | 1 |
Cushman, DW; DeForrest, JM; Fung, WC; Grover, GJ; Harvey, CM; Mitch, SL; Scalese, RJ; Wang, FL | 1 |
2 trial(s) available for ceronapril and Hypertension
Article | Year |
---|---|
Hypotensive effects and influence on serum lipids of SQ29,852, a new angiotensin converting enzyme inhibitor, in patients with essential hypertension: a comparison with atenolol.
Topics: Adult; Aged; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Apolipoproteins; Arteriosclerosis; Atenolol; Blood Pressure; Female; Heart Rate; Humans; Hypertension; Lipids; Lipoproteins; Male; Middle Aged; Organophosphorus Compounds; Phosphatidylcholine-Sterol O-Acyltransferase; Proline | 1993 |
Effect of the ACE inhibitor ceronapril on cerebral blood flow in hypertensive patients.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cerebrovascular Circulation; Chlorthalidone; Diuretics; Drug Therapy, Combination; Female; Homeostasis; Humans; Hypertension; Male; Middle Aged; Organophosphorus Compounds; Proline; Xenon Radioisotopes | 1996 |
8 other study(ies) available for ceronapril and Hypertension
Article | Year |
---|---|
Differential regulation of brain angiotensin II in genetically hypertensive and normotensive rats after nephrectomy.
Topics: Angiotensin II; Animals; Blood Pressure; Brain Chemistry; Hypertension; Male; Nephrectomy; Organophosphorus Compounds; Proline; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renin; Renin-Angiotensin System | 1994 |
Inhibition of angiotensin-converting enzyme modulates the autoregulation of regional cerebral blood flow in hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cerebrovascular Circulation; Homeostasis; Hypertension; Male; Organophosphorus Compounds; Proline; Rats; Rats, Inbred SHR | 1994 |
Ceranapril and cerebral blood flow autoregulation.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cerebrovascular Circulation; Homeostasis; Hypertension; Male; Organophosphorus Compounds; Proline; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Time Factors | 1993 |
Ocular fundus changes in malignant or precocious stroke-prone spontaneously hypertensive rats after administration of antihypertensive drugs.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Arterioles; Blood Pressure; Calcium Channel Blockers; Cerebrovascular Disorders; Dihydropyridines; Fundus Oculi; Histocytochemistry; Hypertension; Male; Nitrobenzenes; Organophosphorus Compounds; Piperazines; Proline; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 1995 |
Effects of chronic treatment with SQ29852 on spontaneous smooth muscle tone and endothelium-dependent relaxation in aorta of stroke-prone spontaneously hypertensive rats.
Topics: Acetylcholine; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Blood Pressure; Captopril; Endothelium, Vascular; Hypertension; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Norepinephrine; Organophosphorus Compounds; Proline; Rats; Rats, Inbred SHR | 1992 |
Hypotensive effect of a phosphorus-containing novel angiotensin converting enzyme inhibitor, (S)-1-[6-amino-2[[hydroxy(4-phenylbutyl)phosphinyl] oxy]-1-oxohexyl]-L-proline (SQ 29,852) in conscious hypertensive dogs.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Animals; Dogs; Enalapril; Female; Hypertension; Organophosphorus Compounds; Proline; Renin | 1992 |
Ceranapril (SQ 29,852), an orally active inhibitor of angiotensin converting enzyme (ACE).
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Dogs; Female; Hypertension; Hypertension, Renovascular; Lung; Macaca fascicularis; Male; Nephrectomy; Organophosphorus Compounds; Proline; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Renal Circulation; Species Specificity | 1990 |
Comparisons in vitro, ex vivo, and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE).
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Bridged Bicyclo Compounds; Captopril; Chemotherapy, Cancer, Regional Perfusion; Dose-Response Relationship, Drug; Enalapril; Fosinopril; Heart; Hypertension; Lisinopril; Male; Organophosphorus Compounds; Proline; Ramipril; Rats; Time Factors; Tissue Distribution | 1989 |